Top 5 biosimilars players the industry wants to hear from

biosimilar, teva, Sandoz, hospira, dr reddys, biocon

In our recent Survey for the 2012 World Biosimilar Congress we asked ‘which generic industry strategy would you like to know more about?'

Are there any surprises amongst the top 5?

Do these match with your opinion or would you like to put another company into the mix? Let us know by commenting below!

Interested in reading more on this topic? Take a look here:

Top drivers fuelling industries biosimilar engagement today

Top strategic considerations when entering the biosimilars market

For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D

Comments 2

  1. Charlottel

    Hi Ben,
    as we’re always looking out for the new companys who are catching the eye of the rest of industry, can I ask why in particular Viropro are of interest to you?

Leave a Reply

Your email address will not be published. Required fields are marked *